Evidence map›Paper›PMID 42619789›Full record

ArticlemedRxiv : the preprint server for health sciences2026

A Multi-Schedule Machine Learning Pipeline for Medicare Reimbursement Change Prediction and Operational Risk Stratification.

Ishan H Patel, Alejandro Leyva, Muhammad Khalid Khan Niazi

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ishan H PatelAI4Path Lab, Department of Pathology, The Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.
Alejandro LeyvaAI4Path Lab, Department of Pathology, The Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.ORCID 0009-0002-0731-9383
Muhammad Khalid Khan NiaziAI4Path Lab, Department of Pathology, The Ohio State University Wexner Medical Center, The Ohio State University, Columbus, OH, USA.

Funding

An ensemble deep learning model for tumor bud detection and risk stratification in colorectal carcinoma.R01CA276301 · NCI · OHIO STATE UNIVERSITY · PI Wei Chen, Muhammad Khalid Khan Niazi · 2023 to 2026
$2.0M
NCI NIH HHS R01 CA276301
6 · The paper itself

Abstract

FeePredict is a three-stage random forest machine learning framework to simultaneously predict whether Medicare reimbursement rates for specific procedures will change, in which direction they will change, and by how much. FeePredict was applied to the four major Medicare fee schedules: the Clinical Laboratory Fee Schedule (CLFS), the Physician Fee Schedule (PFS), the Ambulance Fee Schedule (AFS), and the Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) fee schedule. Each of these fee schedules contains publicly available data from the Centers for Medicare & Medicaid Services (CMS) for the years 2024, 2025, and 2026, with the number of procedures represented in the data ranging from 3,264 to 2,952,842 observations. FeePredict utilizes lag-1 feature engineering and train-only preprocessing steps to ensure that there is no data leakage into the model. Chronological out-of-time validation was performed on three of the four fee schedules to determine the generalizability of the model over time. FeePredict significantly outperformed the assumption that there would be no changes to Medicare reimbursement rates for procedures (

Indexed as

healthcare operationsmachine learningMedicare reimbursementpredictive modelingrisk stratification

Identifiers

PMID42619789
PMCPMC13484305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.